September 20, 2022 Tags: Plastic Surgery News
Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC) is a very rare but potentially aggressive epithelial-based tumor that seems to be associated with breast implants and stems from the breast implant capsule. The American Society of Plastic Surgeons (ASPS)/The Plastic Surgery Foundation (PSF) is aware of so few reported cases of BIA-SCC at this time that it is not possible to determine what factors increase patient risk, however; the ASPS has been in contact with the Food and Drug Administration (FDA) regarding this emerging issue.
On Sept. 8th, 2022, the FDA released a new safety communication about squamous cell carcinoma (SCC) and various lymphomas in the capsule around breast implants. This document is now available to healthcare providers, patients, and caregivers on the FDA’s Medical Device Safety webpage. ASPS/PSF is continuing research and ongoing and persistent surveillance of breast implants to drive patient safety and informed decision-making. The ASPS webpage Breast Implant Safety: What Patients Need to Know contains more information regarding the risk factors of BIA cancers, symptoms, treatment, and more.
You should always speak with a board-certified plastic surgeon before deciding to undergo surgery for a breast implant. Your doctor can communicate risk factors specific to you and your body, as well as help you make the right decision for yourself.
If you’re looking for breast implants in Nashville, contact Dr. J. J. Wendel Plastic Surgery for quality care you can trust. In 2021, Dr. Wendel was recognized as one of America’s Best Plastic Surgeons in Newsweek and has over 20 years of experience and a reputation for providing excellent care and amazing results.